Michael Steiner, PhD

Michael Steiner is a partner with more than 25 years of international experience in the pharmaceutical, biotech and medical technology industries, Dr. Steiner's focus is on M&A transactions, investments, private equity projects, strategy development and turn-around situations of companies.

Experience
Prior to joining JSB-Partners, Dr. Steiner held senior management consulting positions as a partner and global healthcare practice group leader of Bain & Company, New York and The Boston Consulting Group, Munich/ Boston. He was previously a co-founder, and strategic advisor of MPM Capital Boston/ San Francisco. During the 90’s Dr. Steiner served as chairman of the board of 3M-ESPE Seefeld/ Munich, LION bioscience Heidelberg, and PARI Capital Munich/Zurich. He is also a co-founder of Affectis, Munich.

Boards
Dr. Steiner is a member of the board of directors of Max-Planck-Innovation and PARI Capital, Munich/Zurich.

Education
Dr. Steiner earned a Ph.D. in Biochemistry from the Max-Planck-Institute for Biochemistry in Martinsried/ Munich. Part of his Ph.D. work was conducted at the University of California in Irvine and the California Institute of Technology in Pasadena.

Contact
msteiner@jsb-partners.com

© 2012 JSB-Partners, LP, Member SIPC, Member FINRA. Business Continuity Plan. All rights reserved.